Breaking News Instant updates and real-time market news.

DPZ

Domino's Pizza

$209.78

1.78 (0.86%)

06:00
02/15/18
02/15
06:00
02/15/18
06:00

Domino's Pizza price target raised to $235 from $220 at Deutsche Bank

Deutsche Bank analyst Brett Levy raised his price target for Domino's Pizza to $235 ahead of the company's Q4 results on February. The analyst remains comfortable in the company's long-term prospects, competitive advantages and its ability to drive market share gaining same-store-sales. He continues to recommend the shares with a Buy rating.

  • 30

    May

DPZ Domino's Pizza
$209.78

1.78 (0.86%)

01/11/18
MAXM
01/11/18
NO CHANGE
Target $250
MAXM
Buy
Domino's Pizza price target raised to $250 from $240 at Maxim
Maxim analyst Stephen Anderson raised his price target on Domino's Pizza to $250 from $240 after he increased his 2018 and 2019 EPS estimate following the company's analyst day presentation. While Domino's management maintained their long-term growth goals, Anderson said he sees upside to those targets.
01/23/18
FBCO
01/23/18
NO CHANGE
Target $235
FBCO
Outperform
Domino's Pizza price target raised to $235 from $220 at Credit Suisse
Credit Suisse analyst Jason West raised his price target for Domino's Pizza $235 from $220 to reflect the new tax reform. The analyst reiterates an Outperform rating on the shares.
01/24/18
MZHO
01/24/18
INITIATION
Target $250
MZHO
Buy
Domino's Pizza initiated with a Buy at Mizuho
Mizuho analyst Jeremy Scott initiated Domino's Pizza with a Buy and $250 price target.
02/14/18
OPCO
02/14/18
NO CHANGE
Target $230
OPCO
Outperform
Domino's Pizza price target raised to $230 from $220 at Oppenheimer
Oppenheimer analyst Brian Bittner raised his price target for Domino's Pizza to $230 from $220 saying that while it has outperformed peers year-to-date, he remains attracted. The analyst believes Domino's Pizza has tools in 2018 to display the group's best same-store sales, unit expansion and operating profit growth. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

QDEL

Quidel

$48.48

-12.835 (-20.93%)

05:27
12/10/18
12/10
05:27
12/10/18
05:27
Recommendations
Quidel analyst commentary  »

Quidel shares likely flat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:24
12/10/18
12/10
05:24
12/10/18
05:24
Hot Stocks
Roche CEO Daniel O'Day to step down, Genentech CEO William Anderson to succeed »

Roche (RHHBY) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

EA

Electronic Arts

$82.57

-1.29 (-1.54%)

05:22
12/10/18
12/10
05:22
12/10/18
05:22
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

, RHHBY

Roche

$0.00

(0.00%)

05:21
12/10/18
12/10
05:21
12/10/18
05:21
Hot Stocks
Gilead appoints Roche CEO Daniel O'Day as CEO, chairman »

Gilead Sciences announced…

GILD

Gilead

$68.17

-2.01 (-2.86%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

FIVE

Five Below

$95.53

-6.19 (-6.09%)

05:16
12/10/18
12/10
05:16
12/10/18
05:16
Upgrade
Five Below rating change  »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMXAY

Genmab

$0.00

(0.00%)

05:12
12/10/18
12/10
05:12
12/10/18
05:12
Upgrade
Genmab rating change  »

Genmab upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBJY

UCB

$0.00

(0.00%)

05:10
12/10/18
12/10
05:10
12/10/18
05:10
Upgrade
UCB rating change  »

UCB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTUY

Swedish Orphan Biovitrum

$0.00

(0.00%)

05:08
12/10/18
12/10
05:08
12/10/18
05:08
Upgrade
Swedish Orphan Biovitrum rating change  »

Swedish Orphan Biovitrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

, JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

05:06
12/10/18
12/10
05:06
12/10/18
05:06
Upgrade
MorphoSys, Johnson & Johnson rating change  »

MorphoSys upgraded to Buy…

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

SLG

SL Green Realty

$93.32

-2.41 (-2.52%)

05:02
12/10/18
12/10
05:02
12/10/18
05:02
Upgrade
SL Green Realty rating change  »

SL Green Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$74.07

-1.04 (-1.38%)

04:59
12/10/18
12/10
04:59
12/10/18
04:59
Downgrade
Comerica rating change  »

Comerica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

PII

Polaris Industries

$88.44

-2.37 (-2.61%)

04:58
12/10/18
12/10
04:58
12/10/18
04:58
Downgrade
Polaris Industries rating change  »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MPX

Marine Products

$21.59

-0.21 (-0.96%)

04:56
12/10/18
12/10
04:56
12/10/18
04:56
Downgrade
Marine Products rating change  »

Marine Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$67.58

-4.1 (-5.72%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Downgrade
Visteon rating change  »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETQ

PetIQ

$31.46

0.09 (0.29%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
PetIQ management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

HWC

Hancock Whitney

$38.24

0.25 (0.66%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Hancock Whitney management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NBGIF

National Bank of Greece

$0.00

(0.00%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
National Bank of Greece management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

RESI

Front Yard Residential

$9.69

(0.00%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Front Yard Residential management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CORT

Corcept Therapeutics

$13.06

0.01 (0.08%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Corcept Therapeutics management to meet with B.Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

BRG

Bluerock Residential

$9.55

-0.22 (-2.25%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Bluerock Residential management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

KMPR

Kemper

$69.81

-2 (-2.79%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Kemper management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

GRUB

GrubHub

$76.80

-4.57 (-5.62%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
GrubHub management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 14

    Dec

AMAG

Amag Pharmaceuticals

$17.53

-0.58 (-3.20%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Amag Pharmaceuticals management to meet with Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 23

    Mar

ATO

Atmos Energy

$98.80

0.26 (0.26%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Atmos Energy management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

BC

Brunswick

$49.58

-1.56 (-3.05%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Conference/Events
Brunswick management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.